stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Gross margin
Zimmer Biomet Holdings, Inc.'s gross margin over the twelve months to 30 September 2026 was 69.7%, down 0.0 percentage points from fiscal 2025 (69.7%). Over the past ten years it has ranged from 68.9% (fiscal 2016) to 72.7% (fiscal 2017); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 69.7% | (1.75) |
| FY2024 | 71.5% | (0.36) |
| FY2023 | 71.8% | 0.92 |
| FY2022 | 70.9% | (0.39) |
| FY2021 | 71.3% | 1.06 |
| FY2020 | 70.2% | (1.55) |
| FY2019 | 71.8% | 0.42 |
| FY2018 | 71.4% | (1.31) |
| FY2017 | 72.7% | 3.73 |
| FY2016 | 68.9% | (1.04) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 71.2% | 0.37 |
| Jun 2026 | 70.8% | (1.58) |
| Mar 2026 | 72.4% | 7.71 |
| Dec 2025 | 64.7% | (7.37) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| PODD Insulet Corporation compare | 71.9% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. | 69.7% |
| GMED Globus Medical, Inc. compare | 69.1% |
| PEN Penumbra, Inc. compare | 68.0% |
| DXCM DexCom, Inc. compare | 63.4% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc compare | 44.6% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement